He urges consumers to be wary and calls upon the FDA to take stronger regulatory action
If you enjoyed this preview, please consider becoming a paid subscriber!
Patients should not assume that a product is safe because it appears on a polished website or is promoted in fitness, longevity, or peptide communities
[37] [38] See also [edit source] Dipeptidyl peptidase-4 Gastric inhibitory polypeptide GLP-1 receptor agonistsalbiglutide, dulaglutide, exenatide, liraglutide, lixisenatide, tirzepatide, and semaglutide, the last of which is marketed under the brands Ozempic, Rybelsus, and Wegovy
Gastric bypass surgery will usually result in quicker weight loss but data show that at the 24-month point, the numbers are pretty similar